Quality of Life in Sarcoidosis: Assessment and Management

被引:31
作者
De Vries, Jolanda [1 ,2 ,3 ]
Lower, Elyse E. [4 ]
Drent, Marjolein [3 ]
机构
[1] Tilburg Univ, Dept Med Psychol & Neuropsychol, CoRPS, NL-5000 LE Tilburg, Netherlands
[2] St Elizabeth Hosp, Dept Med Psychol, Tilburg, Netherlands
[3] Maastricht Univ, Med Ctr, Sarcoidosis Management Ctr, Maastricht, Netherlands
[4] Univ Cincinnati, Med Ctr, Dept Internal Med, Cincinnati, OH 45267 USA
关键词
Fatigue; sarcoidosis; quality of life; assessment; management; PLACEBO-CONTROLLED TRIAL; FATIGUE ASSESSMENT SCALE; SMALL FIBER NEUROPATHY; HEALTH-STATUS; DOUBLE-BLIND; SLEEP-APNEA; PULMONARY; SYMPTOMS; PATIENT; QUESTIONNAIRE;
D O I
10.1055/s-0030-1262216
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
This review focuses on current knowledge of the QOL (quality of life) and HS (health status) of sarcoidosis patients. The QOL and HS of sarcoidosis patients are impaired and symptoms are a cause of this impairment. Fatigue appears to be the major problem in sarcoidosis patients. QOL is a concept that concerns patients' evaluation of their functioning in a wide range of domains, but always the physical, psychological, and social domain. HS concerns patients' physical, psychological, and social functioning. There are a number of HS questionnaires and one QOL measure that have shown useful in sarcoidosis. In addition, there exists one sarcoidosis-specific HS measure. The main symptom of fatigue can be assessed reliably and valid with the Fatigue Assessment Scale. The absence of objective parameters for experiencing impairment does not always mean that patients are healthy. Because what patients can handle is clearly decreased, the activities should be adapted accordingly. Present studies are generally cross-sectional. There is a need for prospective follow-up studies assessing the natural course of patients' disease in relation to symptoms and QOL.
引用
收藏
页码:485 / 493
页数:9
相关论文
共 69 条
[1]   Chronic fatigue syndrome: A review [J].
Afari, N ;
Buchwald, D .
AMERICAN JOURNAL OF PSYCHIATRY, 2003, 160 (02) :221-236
[2]   Quality of life in patients with active sarcoidosis in Greece [J].
Antoniou, Katerina M. ;
Tzanakis, Nikolaos ;
Tzouvelekis, Argyris ;
Samiou, Maria ;
Symvoulakis, Emmanouil K. ;
Siafakas, Nikolaos M. ;
Bouros, Demosthenes .
EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2006, 17 (06) :421-426
[3]  
Baughman RP, 2009, SARCOIDOSIS VASC DIF, V26, P110
[4]   Six-minute walk test and health status assessment in sarcoidosis [J].
Baughman, Robert P. ;
Sparkman, Brian K. ;
Lower, Elyse E. .
CHEST, 2007, 132 (01) :207-213
[5]   Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement [J].
Baughman, Robert P. ;
Drent, Marjolein ;
Kavuru, Mani ;
Judson, Marc A. ;
Costabel, Ulrich ;
du Bois, Roland ;
Albera, Carlo ;
Brutsche, Martin ;
Davis, Gerald ;
Donohue, James F. ;
Mueller-Quernheim, Joachim ;
Schlenker-Herceg, Rozsa ;
Flavin, Susan ;
Lo, Kim Hung ;
Oemar, Barry ;
Barnathan, Elliot S. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2006, 174 (07) :795-802
[6]  
Baughman RP, 2002, SARCOIDOSIS VASC DIF, V19, P198
[7]   THE SICKNESS IMPACT PROFILE - DEVELOPMENT AND FINAL REVISION OF A HEALTH-STATUS MEASURE [J].
BERGNER, M ;
BOBBITT, RA ;
CARTER, WB ;
GILSON, BS .
MEDICAL CARE, 1981, 19 (08) :787-805
[8]  
Bowling A., 1995, MEASURING DIS REV DI
[9]   Importance of differentiating health status from quality of life [J].
Bradley, C .
LANCET, 2001, 357 (9249) :7-8
[10]   Assessment of disease impact in patients with intermittent claudication: Discrepancy between health status and quality of life [J].
Breek, JC ;
de Vries, J ;
van Heck, GL ;
Henegouwen, DPV ;
Hamming, JF .
JOURNAL OF VASCULAR SURGERY, 2005, 41 (03) :443-450